Literature DB >> 10705301

Interleukin-12 induced interferon-gamma increases inflammation in acute dextran sulfate sodium induced colitis in mice.

W Hans1, J Schölmerich, V Gross, W Falk.   

Abstract

There is increasing evidence that IL-12 and Th1-cytokines play an important role in intestinal inflammation. We therefore examined the role of IL-12 and interferon-gamma (IFN-gamma) in our model of dextran sulfate-induced acute colitis in mice. Treatment of mice with rmIL-12 during colitis induction resulted in severe aggravation as demonstrated by a greater loss of body weight, an increase of the histological parameters, and reduction of myeloperoxidase activity in colonic biopsies. Depletion of neutrophils in mice also led to aggravation of colitis. Neutralization of IFN-gamma in IL-12-treated mice with colitis inhibited these effects of IL-12. Neutralization of endogenous IFN-gamma or IL-12 with specific antibodies in DSS-treated mice, however, had only weak ameliorating effects. Since IL-12 and IFN-gamma have been shown to mediate experimental chronic colitis we conclude that the transition from a macrophage/neutrophil determined response to a Th-cell response promotes chronic intestinal inflammation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10705301

Source DB:  PubMed          Journal:  Eur Cytokine Netw        ISSN: 1148-5493            Impact factor:   2.737


  17 in total

1.  Intestinal mononuclear cells primed by systemic interleukin-12 display long-term ability to aggravate colitis in mice.

Authors:  Luciano P Pedrotti; Angela A Sena; María Cecilia Rodriguez Galán; Hugo Cejas; Silvia G Correa
Journal:  Immunology       Date:  2016-11-27       Impact factor: 7.397

2.  The atypical cannabinoid O-1602 protects against experimental colitis and inhibits neutrophil recruitment.

Authors:  Rudolf Schicho; Mohammad Bashashati; Misha Bawa; Douglas McHugh; Dieter Saur; Huang-Ming Hu; Andreas Zimmer; Beat Lutz; Ken Mackie; Heather B Bradshaw; Donna-Marie McCafferty; Keith A Sharkey; Martin Storr
Journal:  Inflamm Bowel Dis       Date:  2010-11-15       Impact factor: 5.325

3.  Analysis of intestinal haem-oxygenase-1 (HO-1) in clinical and experimental colitis.

Authors:  G Paul; F Bataille; F Obermeier; J Bock; F Klebl; U Strauch; D Lochbaum; P Rümmele; S Farkas; J Schölmerich; M Fleck; G Rogler; H Herfarth
Journal:  Clin Exp Immunol       Date:  2005-06       Impact factor: 4.330

4.  Interferon-gamma is causatively involved in experimental inflammatory bowel disease in mice.

Authors:  R Ito; M Shin-Ya; T Kishida; A Urano; R Takada; J Sakagami; J Imanishi; M Kita; Y Ueda; Y Iwakura; K Kataoka; T Okanoue; O Mazda
Journal:  Clin Exp Immunol       Date:  2006-11       Impact factor: 4.330

5.  Epithelial toll-like receptor 5 is constitutively localized in the mouse cecum and exhibits distinctive down-regulation during experimental colitis.

Authors:  Cesar F Ortega-Cava; Shunji Ishihara; Mohammad A K Rumi; M M Aziz; Hideaki Kazumori; Takafumi Yuki; Yoshiyuki Mishima; Ichiro Moriyama; Chikara Kadota; Naoki Oshima; Yuji Amano; Yasunori Kadowaki; Norihisa Ishimura; Yoshikazu Kinoshita
Journal:  Clin Vaccine Immunol       Date:  2006-01

6.  Interleukin 18 is a primary mediator of the inflammation associated with dextran sulphate sodium induced colitis: blocking interleukin 18 attenuates intestinal damage.

Authors:  P V Sivakumar; G M Westrich; S Kanaly; K Garka; T L Born; J M J Derry; J L Viney
Journal:  Gut       Date:  2002-06       Impact factor: 23.059

7.  Noncanonical Effects of IRF9 in Intestinal Inflammation: More than Type I and Type III Interferons.

Authors:  Isabella Rauch; Felix Rosebrock; Eva Hainzl; Susanne Heider; Andrea Majoros; Sebastian Wienerroither; Birgit Strobl; Silvia Stockinger; Lukas Kenner; Mathias Müller; Thomas Decker
Journal:  Mol Cell Biol       Date:  2015-04-27       Impact factor: 4.272

8.  Hyaluronan-mediated leukocyte adhesion and dextran sulfate sodium-induced colitis are attenuated in the absence of signal transducer and activator of transcription 1.

Authors:  Sudip K Bandyopadhyay; Carol A de la Motte; Sean P Kessler; Vincent C Hascall; David R Hill; Scott A Strong
Journal:  Am J Pathol       Date:  2008-09-25       Impact factor: 4.307

9.  A novel Toll-like receptor 4 antagonist antibody ameliorates inflammation but impairs mucosal healing in murine colitis.

Authors:  Ryan Ungaro; Masayuki Fukata; David Hsu; Yasmin Hernandez; Keith Breglio; Anli Chen; Ruliang Xu; John Sotolongo; Cecillia Espana; Julia Zaias; Greg Elson; Lloyd Mayer; Marie Kosco-Vilbois; Maria T Abreu
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-04-09       Impact factor: 4.052

10.  The GPR55 antagonist CID16020046 protects against intestinal inflammation.

Authors:  A Stančić; K Jandl; C Hasenöhrl; F Reichmann; G Marsche; R Schuligoi; A Heinemann; M Storr; R Schicho
Journal:  Neurogastroenterol Motil       Date:  2015-07-30       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.